论文部分内容阅读
目的:探讨用脑脉利颗粒对脑梗塞恢复期患者进行治疗的临床效果。方法:对2011年3月~2013年4月期间我中心收治的60例脑梗塞恢复期患者的临床资料进行回顾性研究。我们将这60例患者随机分为观察组和对照组,每组各有30例患者。我中心对对照组患者进行常规药物治疗,对观察组患者在进行常规药物治疗(方法与对照组患者相同)的基础上,加用脑脉利颗粒进行治疗。治疗结束后,比较两组患者治疗前后NIHSS(神经功能缺损程度)的评分、日常生活活动能力的评分、治疗的效果和发生不良反应的情况。结果:观察组患者治疗后的NIHSS评分明显低于对照组患者,其治疗后日常生活活动能力的评分明显高于对照组患者,二者相比差异具有显著性(P<0.05)。观察组患者治疗的总有效率明显高于对照组患者,二者相比差异具有显著性(P<0.05)。两组患者发生不良反应的几率大体相同,二者相比差异无显著性(P>0.05)。结论:用脑脉利颗粒对脑梗塞恢复期患者进行治疗可有效地改善其神经功能缺损的症状,提高其日常生活活动能力,而且安全性高。此疗法值得在临床上推广使用。
Objective: To explore the clinical effect of using Naomaili Granule in the treatment of patients with cerebral infarction recovery. Methods: The clinical data of 60 patients with convalescence of cerebral infarction treated in our center from March 2011 to April 2013 were retrospectively studied. We randomly divided the 60 patients into observation and control groups, each with 30 patients in each group. My center of the control group of patients with conventional drug treatment, the observation group of patients in the conventional drug treatment (the same method as in the control group), based on the addition of naomaili particles for treatment. After treatment, NIHSS score, daily living activity score, treatment effect and adverse reactions were compared between the two groups before and after treatment. Results: The scores of NIHSS after treatment in observation group were significantly lower than those in control group. The scores of activities of daily living in treatment group were significantly higher than those in control group after treatment. The difference was significant (P <0.05). The total effective rate of observation group was significantly higher than that of the control group, the difference was significant (P <0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). Conclusion: The treatment of patients with cerebral infarction convalescence with Naomaili Granules can effectively improve the symptoms of neurological deficits and improve their activities of daily living, and is safe. This therapy is worth promoting in clinic.